Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
breast neoplasms
,
male breast neoplasms
Eribulin
lymphoma
,
skin neoplasms
,
cutaneous malignant melanoma
,
abdominal neoplasms
,
retroperitoneal neoplasms
,
renal insufficiency
,
ovarian neoplasms
,
ovarian epithelial carcinoma
,
lung neoplasms
,
prostatic neoplasms
,
liposarcoma
,
inflammatory breast neoplasms
,
melanoma
,
leiomyosarcoma
,
colorectal neoplasms
,
urethral neoplasms
,
ureteral neoplasms
,
renal cell carcinoma
,
fallopian tube neoplasms
,
head and neck neoplasms
,
ewing sarcoma
,
rhabdomyosarcoma
,
pancreatic neoplasms
,
pelvic neoplasms
,
colonic neoplasms
,
fatigue
,
circulating neoplastic cells
,
postmenopause
,
soft tissue neoplasms
,
malignant fibrous histiocytoma
,
residual neoplasm
,
solitary fibrous tumors
,
hemangiopericytoma
,
fibrous tissue neoplasms
,
hemangiosarcoma
,
epithelioid hemangioendothelioma
,
osteosarcoma
,
uterine cervical neoplasms
,
salivary gland neoplasms
,
castration-resistant prostatic neoplasms
,
uterine neoplasms
,
carcinosarcoma
,
mullerian mixed tumor
,
hepatocellular carcinoma
,
drug therapy
,
triple negative breast neoplasms
,
neoplasms
,
sarcoma
,
neoplasm metastasis
,
recurrence
,
carcinoma
,
non-small-cell lung carcinoma
,
brain neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
urologic neoplasms
,
hereditary breast and ovarian cancer syndrome
,
adenocarcinoma
,
brca2 genes
,
invasive hydatidiform mole
,
meningeal neoplasms
,
meningeal carcinomatosis
,
mutation
,
breast neoplasms
,
male breast neoplasms
,
drug-related side effects and adverse reactions
,
neurotoxicity syndromes
,
peripheral nervous system diseases
,
alopecia areata
,
alopecia
,
treatment outcome
Eribulin mesylate
breast neoplasms
,
neoplasms
Sacituzumab
breast neoplasms
Mycophenolate sodium
kidney transplantation
,
focal segmental glomerulosclerosis
Benzimidazole
non-hodgkin lymphoma
,
ulcerative colitis
,
crohn disease
,
colitis
,
ulcer
,
psoriasis
,
rheumatoid arthritis
,
arthritis
,
pharmacokinetics
,
neoplasms
,
multiple myeloma
,
plasma cell neoplasms
,
glioblastoma
,
glioma
,
gliosarcoma
,
astrocytoma
,
diffuse intrinsic pontine glioma
,
optic nerve glioma
,
brain stem neoplasms
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
syndrome
,
healthy volunteers/patients
,
lymphoma
,
peptic esophagitis
,
peripheral arterial disease
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
mantle-cell lymphoma
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
infections
,
communicable diseases
,
helminthiasis
,
vomiting
,
gastroenteritis
,
heartburn
,
non-erosive reflux disease
,
asthma
,
gastroesophageal reflux
,
sleep initiation and maintenance disorders
,
sleep wake disorders
,
parasomnias
,
atrial fibrillation
,
venous thromboembolism
,
thromboembolism
,
stroke
,
schizophrenia
,
sudden death cardiac
,
death
,
sudden death
Sintilimab
non-small-cell lung carcinoma
,
lung neoplasms
Penpulimab
neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
gastrointestinal neoplasms
,
colorectal neoplasms
,
pancreatic neoplasms
,
nasopharyngeal neoplasms
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
thyroid neoplasms
,
small cell lung carcinoma
,
glioblastoma
,
stomach neoplasms
,
gastrointestinal diseases
,
digestive system diseases
,
nasopharyngeal carcinoma
,
rectal neoplasms
,
lymphoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
squamous cell neoplasms
,
esophageal squamous cell carcinoma
,
sarcoma
,
melanoma
,
pheochromocytoma
,
carcinoma
,
hepatocellular carcinoma
,
liver neoplasms
Lanifibranor
healthy volunteers/patients
,
pharmacokinetics
,
fatty liver
,
type 2 diabetes mellitus
,
diabetes mellitus
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
non-alcoholic fatty liver disease
,
liver diseases
,
fibrosis
Gilvetmab
lung neoplasms
,
small cell lung carcinoma
,
neoplasms
,
melanoma
,
urinary bladder neoplasms
,
esophageal squamous cell carcinoma
,
triple negative breast neoplasms
,
malignant mesothelioma
,
breast neoplasms
,
glioblastoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
neoplasm metastasis
,
tumor virus infections
,
non-small-cell lung carcinoma
Enoblituzumab
depression
,
hypertension
,
malnutrition
,
infections
,
healthy volunteers/patients
,
rheumatoid arthritis
,
hypersensitivity
,
prostatic neoplasms
,
hirsutism
,
inflammation
,
type 2 diabetes mellitus
,
vomiting
,
nausea
,
pain
,
epilepsy
,
bipolar disorder
,
rheumatic diseases
,
immunosuppression therapy
,
psoriatic arthritis
,
arthritis
,
seizures
,
anxiety
,
migraine disorders
,
headache
,
chest pain
,
osteoarthritis
,
angina pectoris
,
diarrhea
Efbemalenograstim alfa
neutropenia
,
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
ovarian neoplasms
,
uterine cervical neoplasms
Aglatimagene besadenovec
neoplasms
Spartalizumab
kidney diseases
,
kidney neoplasms
,
neoplasm metastasis
Lenograstim
aids-related complex
,
aggression
,
neuroblastoma
,
central nervous system neoplasms
,
germ cell and embryonal neoplasms
,
liver neoplasms
,
nervous system neoplasms
,
non-hodgkin lymphoma
,
lymphoma
,
hiv infections
,
multiple myeloma
,
lung neoplasms
,
neutropenia
,
plasma cell neoplasms
,
non-small-cell lung carcinoma
,
hodgkin disease
,
sarcoma
,
acquired immunodeficiency syndrome
,
ovarian neoplasms
,
myeloid leukemia acute
,
neoplasms
,
pancytopenia
,
cytopenia
,
b-cell lymphoma
,
prostatic neoplasms
,
pain
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
oncogenes
,
bone neoplasms
,
recurrence
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
burkitt lymphoma
,
type 1 diabetes mellitus
,
myeloproliferative disorders
,
hematologic diseases
,
aplastic anemia
,
blast crisis
,
kaposi sarcoma
,
breast neoplasms
,
leukemia
,
myeloid leukemia
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
graft vs host disease
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use